209 related articles for article (PubMed ID: 34555842)
1. A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival.
Lamaison C; Latour S; Hélaine N; Le Morvan V; Saint-Vanne J; Mahouche I; Monvoisin C; Dussert C; Andrique L; Deleurme L; Dessauge E; Pangault C; Baulande S; Legoix P; Seffals M; Broca-Brisson L; Alessandri K; Carlotti M; Soubeyran P; Merlio JP; Mourcin F; Nassoy P; Recher G; Tarte K; Bresson-Bepoldin L
Blood Adv; 2021 Dec; 5(23):5372-5386. PubMed ID: 34555842
[TBL] [Abstract][Full Text] [Related]
2. Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities.
Brauge B; Dessauge E; Creusat F; Tarte K
Front Immunol; 2023; 14():1288110. PubMed ID: 38022603
[TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
4. Development and Characterization of 3D Hybrid Spheroids for the Investigation of the Crosstalk Between B-Cell Non-Hodgkin Lymphomas and Mesenchymal Stromal Cells.
Duś-Szachniewicz K; Gdesz-Birula K; Rymkiewicz G
Onco Targets Ther; 2022; 15():683-697. PubMed ID: 35747403
[TBL] [Abstract][Full Text] [Related]
5. Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells.
Tian YF; Ahn H; Schneider RS; Yang SN; Roman-Gonzalez L; Melnick AM; Cerchietti L; Singh A
Biomaterials; 2015 Dec; 73():110-9. PubMed ID: 26406451
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
Faria C; Gava F; Gravelle P; Valero JG; Dobaño-López C; Van Acker N; Quelen C; Jalowicki G; Morin R; Rossi C; Lagarde JM; Fournié JJ; Ysebaert L; Laurent C; Pérez-Galán P; Bezombes C
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899130
[TBL] [Abstract][Full Text] [Related]
7. Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms.
Dumontet E; Mancini SJC; Tarte K
Front Immunol; 2021; 12():784691. PubMed ID: 34956214
[TBL] [Abstract][Full Text] [Related]
8. Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy.
Foxall R; Narang P; Glaysher B; Hub E; Teal E; Coles MC; Ashton-Key M; Beers SA; Cragg MS
Front Immunol; 2020; 11():605231. PubMed ID: 33628205
[TBL] [Abstract][Full Text] [Related]
9. A three-dimensional spheroidal cancer model based on PEG-fibrinogen hydrogel microspheres.
Pradhan S; Clary JM; Seliktar D; Lipke EA
Biomaterials; 2017 Jan; 115():141-154. PubMed ID: 27889665
[TBL] [Abstract][Full Text] [Related]
10. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment.
Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C
Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032
[TBL] [Abstract][Full Text] [Related]
11. Role of the microenvironment across histological subtypes of NHL.
Tarte K
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):610-617. PubMed ID: 29222311
[TBL] [Abstract][Full Text] [Related]
12. Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma.
Mahadevan D; Stejskal A; Cooke LS; Manziello A; Morales C; Persky DO; Fisher RI; Miller TP; Qi W
Clin Cancer Res; 2012 Apr; 18(8):2210-9. PubMed ID: 22374334
[TBL] [Abstract][Full Text] [Related]
13. TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation.
Munoz O; Fend F; de Beaumont R; Husson H; Astier A; Freedman AS
Leukemia; 2004 Dec; 18(12):2015-25. PubMed ID: 15470494
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas.
Grégoire M; Guilloton F; Pangault C; Mourcin F; Sok P; Latour M; Amé-Thomas P; Flecher E; Fest T; Tarte K
Oncotarget; 2015 Jun; 6(18):16471-87. PubMed ID: 26158216
[TBL] [Abstract][Full Text] [Related]
15. The challenge of the microenvironment in B-cell lymphomas.
Coupland SE
Histopathology; 2011 Jan; 58(1):69-80. PubMed ID: 21261684
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW.
Adams CM; Mitra R; Gong JZ; Eischen CM
Clin Cancer Res; 2017 Nov; 23(22):7119-7129. PubMed ID: 28855351
[No Abstract] [Full Text] [Related]
17. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
18. Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140.
Beider K; Ribakovsky E; Abraham M; Wald H; Weiss L; Rosenberg E; Galun E; Avigdor A; Eizenberg O; Peled A; Nagler A
Clin Cancer Res; 2013 Jul; 19(13):3495-507. PubMed ID: 23637121
[TBL] [Abstract][Full Text] [Related]
19. Proliferation of non-Hodgkin-lymphoma lymphocytes in vitro is dependent upon follicular dendritic cell interactions.
Petrasch S; Kosco M; Perez-Alvarez C; Schmitz J; Brittinger G
Br J Haematol; 1992 Jan; 80(1):21-6. PubMed ID: 1536807
[TBL] [Abstract][Full Text] [Related]
20. 3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma.
Gava F; Faria C; Gravelle P; Valero JG; Dobaño-López C; Morin R; Norlund M; Gomes A; Lagarde JM; Rossi C; Bordenave J; Pieruccioni L; Rouquette J; Matas-Céspedes A; Fournié JJ; Ysebaert L; Laurent C; Pérez-Galán P; Bezombes C
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33804934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
